Growth and Tolerance of Term Infants Fed Formula With Probiotic Lactobacillus reuteri
- PMID: 25758426
- DOI: 10.1177/0009922815574076
Growth and Tolerance of Term Infants Fed Formula With Probiotic Lactobacillus reuteri
Abstract
Background: Lactobacillus reuteri has been studied for its safety and beneficial effects in infants. This study assessed growth of infants fed a partially hydrolyzed whey formula with L reuteri.
Methods: Healthy term infants were randomized to 1 of 2 formulas (partially hydrolyzed whey formula with (PRO) or without (CON) L reuteri from 14 to 112 days of age. Anthropometric measures were assessed at 14, 28, 56, 84, and 112 days of age. Tolerance records were completed 2 days prior to each visit.
Results: A total of 122 subjects completed study per protocol (60 PRO, 62 CON). No differences were seen in daily weight gain, length, or head circumference. Overall, between groups, there were no significant differences in formula intake, stool frequency, color, consistency, flatulence, frequency of spit-up/vomiting, mood, sleep, or incidence of adverse events.
Conclusion: Infants fed probiotic formula had similar growth to infants fed control formula. Both formulas were well tolerated.
Keywords: Lactobacillus reuteri; infant formula; infant growth; lactose; probiotic.
© The Author(s) 2015.
Similar articles
-
Growth, Gastrointestinal Tolerance and Stool Characteristics of Healthy Term Infants Fed an Infant Formula Containing Hydrolyzed Whey Protein (63%) and Intact Casein (37%): A Randomized Clinical Trial.Nutrients. 2017 Nov 16;9(11):1254. doi: 10.3390/nu9111254. Nutrients. 2017. PMID: 29144393 Free PMC article. Clinical Trial.
-
Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study.J Am Coll Nutr. 2006 Oct;25(5):415-9. doi: 10.1080/07315724.2006.10719554. J Am Coll Nutr. 2006. PMID: 17031011 Clinical Trial.
-
Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study.Nutrients. 2023 Jan 19;15(3):530. doi: 10.3390/nu15030530. Nutrients. 2023. PMID: 36771237 Free PMC article.
-
Milk protein-based infant formula containing rice starch and low lactose reduces common regurgitation in healthy term infants: a randomized, blinded, and prospective trial.J Am Coll Nutr. 2014;33(2):136-46. doi: 10.1080/07315724.2013.828578. J Am Coll Nutr. 2014. PMID: 24724771 Review.
-
Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis.Pediatrics. 2018 Jan;141(1):e20171811. doi: 10.1542/peds.2017-1811. Pediatrics. 2018. PMID: 29279326 Review.
Cited by
-
Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.Nutr J. 2022 Feb 22;21(1):11. doi: 10.1186/s12937-022-00764-2. Nutr J. 2022. PMID: 35193609 Free PMC article. Clinical Trial.
-
Probiotic Supplementation During the Perinatal and Infant Period: Effects on Gut Dysbiosis and Disease.Nutrients. 2020 Jul 27;12(8):2243. doi: 10.3390/nu12082243. Nutrients. 2020. PMID: 32727119 Free PMC article.
-
A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas.Int J Pediatr. 2018 Nov 1;2018:4969576. doi: 10.1155/2018/4969576. eCollection 2018. Int J Pediatr. 2018. PMID: 30515226 Free PMC article.
-
Using probiotics in paediatric populations.Paediatr Child Health. 2022 Dec 27;27(8):482-502. doi: 10.1093/pch/pxac087. eCollection 2022 Dec. Paediatr Child Health. 2022. PMID: 36583073 Free PMC article. Review. English, French, French.
-
Role of Lactobacillus reuteri in Human Health and Diseases.Front Microbiol. 2018 Apr 19;9:757. doi: 10.3389/fmicb.2018.00757. eCollection 2018. Front Microbiol. 2018. PMID: 29725324 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical